FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

929360081000036101: Medicinal product pack reference set (foundation metadata concept)


Status: current, Primitive. Date: 31-Mar 2011. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3288201000168119 MPP (medicinal product pack) reference set en Synonym Active Case sensitive Australian Medicines Terminology module
965507131000036117 Medicinal product pack reference set en Synonym Active Case sensitive Australian Medicines Terminology module
965507141000036110 Medicinal product pack reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4351131000168114 <p>Terminology to describe in a health record an abstract concept representing the properties of one or more quantitatively and clinically equivalent Trade Product Packs.</p><p>This reference set supports the accurate and unambiguous electronic communication and exchange of medicines information between clinicians for medication management and the recording of adverse reactions.</p><p><b>Target client: </b>NCTS</p> en Definition Active Case sensitive Australian Medicines Terminology module


15976 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Medicinal product pack reference set Has licence SNOMED CT-AU licence​ true Inferred relationship Some 1740441059
Medicinal product pack reference set Developed by Australian Digital Health Agency true Inferred relationship Some 991480534
Medicinal product pack reference set Is a Simple type reference set true Inferred relationship Some

Members
imatinib 100 mg capsule, 96
imatinib 100 mg tablet, 100
imatinib 100 mg tablet, 120
imatinib 100 mg tablet, 180
imatinib 100 mg tablet, 500
imatinib 100 mg tablet, 56
imatinib 100 mg tablet, 60
imatinib 100 mg tablet, 90
imatinib 400 mg capsule, 120
imatinib 400 mg capsule, 180
imatinib 400 mg capsule, 24
imatinib 400 mg capsule, 30
imatinib 400 mg capsule, 48
imatinib 400 mg capsule, 96
imatinib 400 mg tablet, 100
imatinib 400 mg tablet, 28
imatinib 400 mg tablet, 30
imatinib 400 mg tablet, 500
imatinib 400 mg tablet, 90
imatinib 50 mg capsule, 30 capsules (medicinal product pack)
imatinib 600 mg tablet, 30
imdevimab 120 mg/mL injection, 11.1 mL vial
imdevimab 120 mg/mL injection, 2.5 mL vial
imiglucerase 200 units injection, 1 vial
imiglucerase 400 units injection, 1 vial
imipramine hydrochloride 10 mg tablet, 100
imipramine hydrochloride 10 mg tablet, 50
imipramine hydrochloride 25 mg tablet, 100
imipramine hydrochloride 25 mg tablet, 1000
imipramine hydrochloride 25 mg tablet, 50
imiquimod 5% cream, 250 mg sachet
imiquimod 5% cream, 12 x 250 mg sachets
imiquimod 5% cream, 24 x 250 mg sachets
imiquimod 5% cream, 3 x 250 mg sachets
imiquimod 5% cream, 30 x 250 mg sachets
imiquimod 5% cream, 6 x 250 mg sachets
imiquimod 5% cream, 2 g
imiquimod 5% cream, 2 x 2 g
inclisiran 284 mg/1.5 mL injection, 1.5 mL syringe
incobotulinumtoxinA 100 units injection, 1 vial
incobotulinumtoxinA 50 units injection, 1 vial
indacaterol 125 microgram + mometasone furoate 127.5 microgram powder for inhalation, 10 capsules
indacaterol 125 microgram + mometasone furoate 127.5 microgram powder for inhalation, 30 capsules
indacaterol 125 microgram + mometasone furoate 260 microgram powder for inhalation, 10 capsules
indacaterol 125 microgram + mometasone furoate 260 microgram powder for inhalation, 30 capsules
indacaterol 125 microgram + mometasone furoate 62.5 microgram powder for inhalation, 10 capsules
indacaterol 125 microgram + mometasone furoate 62.5 microgram powder for inhalation, 30 capsules
indacaterol 150 microgram powder for inhalation, 10 capsules
indacaterol 150 microgram powder for inhalation, 30 capsules
indacaterol 150 microgram powder for inhalation, 60 capsules
indacaterol 300 microgram powder for inhalation, 30 capsules
indapamide hemihydrate 1.25 mg + perindopril arginine 5 mg tablet, 10 tablets (medicinal product pack)
perindopril arginine 5 mg + indapamide hemihydrate 1.25 mg tablet, 30
perindopril erbumine 4 mg + indapamide hemihydrate 1.25 mg tablet, 30
indapamide hemihydrate 1.5 mg modified release tablet, 10
indapamide hemihydrate 1.5 mg modified release tablet, 30
indapamide hemihydrate 1.5 mg modified release tablet, 90
indapamide hemihydrate 2.5 mg tablet, 10
indapamide hemihydrate 2.5 mg tablet, 30
indapamide hemihydrate 2.5 mg tablet, 60
indapamide hemihydrate 2.5 mg tablet, 90 tablets (medicinal product pack)
perindopril arginine 2.5 mg + indapamide hemihydrate 625 microgram tablet, 10
perindopril arginine 2.5 mg + indapamide hemihydrate 625 microgram tablet, 30
perindopril erbumine 2 mg + indapamide hemihydrate 625 microgram tablet, 10
perindopril erbumine 2 mg + indapamide hemihydrate 625 microgram tablet, 30
indigo carmine 20 mg/5 mL injection, 5 x 5 mL ampoules
indigo carmine 0.4% (20 mg/5 mL) solution, 5 x 5 mL syringes
indigo carmine 0.4% (60 mg/15 mL) solution, 10 x 15 mL vials
indinavir 100 mg capsule, 180
indinavir 200 mg capsule, 360
indinavir 400 mg capsule, 180
indinavir 400 mg capsule, 42
indinavir 400 mg capsule, 6
indinavir 400 mg capsule, 84
indium (111In) chloride 111 MBq/mL injection [1 mL vial] (&) pentetreotide 10 microgram injection [1 vial], 1 pack
indium (111In) chloride 111 MBq/mL injection, 1 mL vial
indometacin 1 mg injection, 3 vials
indometacin 100 mg suppository, 20
indometacin 25 mg capsule, 1000
indometacin 25 mg capsule, 250
indometacin 25 mg capsule, 30
indometacin 25 mg capsule, 50
indometacin 25 mg capsule, 6
indometacin 25 mg capsule, 90
industrial methylated spirit 1 g/mL solution, 500 mL
leuprorelin acetate 22.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe], 1 pack
leuprorelin acetate 30 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe], 1 pack
leuprorelin acetate 45 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe], 1 pack
leuprorelin acetate 7.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe], 1 pack
measles 1000 TCID50 units + mumps 12 500 TCID50 units + rubella 1000 TCID50 units live vaccine injection [1 vial] (&) inert substance diluent [1 syringe], 1 pack
measles 1000 TCID50 units + mumps 20 000 TCID50 units + rubella 1000 TCID50 units + varicella-zoster 9772 PFU live vaccine injection [1 vial] (&) inert substance diluent [1 syringe], 1 pack
pegvisomant 20 mg injection [1 vial] (&) inert substance diluent [1 syringe], 1 pack
inert substance diluent [1 syringe] (&) rotavirus serotype G1P1A(8) live antigen 1 million CCID50 units powder for oral liquid [1 x 1 million CCID50 units vial], 1 pack (medicinal product pack)
Japanese encephalitis live vaccine injection [1 vial] (&) inert substance diluent [1 vial], 1 pack
lonoctocog alfa 1000 units injection [1 vial] (&) inert substance diluent [1 vial], 1 pack
inert substance diluent [1 vial] (&) lonoctocog alfa 1500 international units injection [1 x 1500 international unit vial], 1 pack (medicinal product pack)
lonoctocog alfa 2000 units injection [1 vial] (&) inert substance diluent [1 vial], 1 pack
lonoctocog alfa 2500 units injection [1 vial] (&) inert substance diluent [1 vial], 1 pack
lonoctocog alfa 3000 units injection [1 vial] (&) inert substance diluent [1 vial], 1 pack
lonoctocog alfa 500 units injection [1 vial] (&) inert substance diluent [1 vial], 1 pack
pegvisomant 20 mg injection [1 vial] (&) inert substance diluent [1 vial], 1 pack

Start Previous Page 90 of 160 Next End


Reference Sets

Reference set descriptor

Back to Start